Although several studies have reported the effect of RASSF1A methylation on the prognosis of patients with different types of cancer, the results are inconsistent across different studies [13–15] and vary even within the same cancer type, such as gastric cancer (GC) [13, 16] and breast cancer (BC) [14, 17]. This evidence concerns the gene RASSF1 and breast cancer.